HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[A case of disseminated tumor from cecal cancer with survival for over 5 years after twice surgical resection and systemic chemotherapy].

Abstract
A 66-year-old man underwent a curative operation for cecal cancer on the 30th of November, 1998. Since his CEA level rose in January 2001, computed tomography (CT) revealed a tumor in the abdomen. He underwent a resection of this tumor and disseminated tumors that were diagnosed during the operation. He received systemic chemotherapy (5'-DFUR 600 mg 3x everyday, CPT-11 80 mg/body div every 2 weeks), but the CEA level rose again in August 2003. He was diagnosed with spleen metastasis and underwent splenectomy. The tumor disseminated in the left diaphragm was also resected. After that, he received systemic chemotherapy (5-FU 500 mg/body/week div, levofolinate calcium 250 mg/body/week i.v.) as an outpatient. Peritoneal carcinomatosis from colorectal cancer with distant metastasis, in general, has no indication for an operation. However, if dissemination is located after a sufficient observation period, its resection may be recommended.
AuthorsTakao Tamesa, Yusaku Watanabe, Kiyoshi Yoshimura, Naohide Mori, Shigeru Yamamoto, Shoichi Hazama, Akira Tangoku, Masaaki Oka
JournalGan to kagaku ryoho. Cancer & chemotherapy (Gan To Kagaku Ryoho) Vol. 31 Issue 11 Pg. 1864-6 (Oct 2004) ISSN: 0385-0684 [Print] Japan
PMID15553741 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Carcinoembryonic Antigen
  • Floxuridine
  • Irinotecan
  • Leucovorin
  • Fluorouracil
  • doxifluridine
  • Camptothecin
Topics
  • Adenocarcinoma (mortality, pathology, therapy)
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols (administration & dosage)
  • Camptothecin (administration & dosage, analogs & derivatives)
  • Carcinoembryonic Antigen (blood)
  • Cecal Neoplasms (mortality, pathology, therapy)
  • Combined Modality Therapy
  • Floxuridine (administration & dosage)
  • Fluorouracil (administration & dosage)
  • Humans
  • Irinotecan
  • Leucovorin (administration & dosage)
  • Male
  • Neoplasm Seeding
  • Peritoneal Neoplasms (secondary, therapy)
  • Reoperation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: